Aparna Balasubramanian

Medicine & Life Sciences

1. Chronic Obstructive Pulmonary Disease 100%
2. Pulmonary Arterial Hypertension 69%
3. Pulmonary Hypertension 58%
4. Polycythemia 40%
5. Pectoralis Muscles 35%
6. Right Ventricular Function 33%
7. Mortality 31%
8. Hemoglobins 30%
9. Systemic Scleroderma 30%
10. Carbon Monoxide 26%
11. Emphysema 25%
12. Oxygen 25%
13. Smokers 24%
14. Hospitalization 23%
15. Risk Assessment 21%
16. Intensive Care Units 21%
17. Health Care Outcome Assessment 21%
18. Disease Progression 21%
19. Biomarkers 19%
20. Morbidity 18%
21. Muscles 15%
22. Survival 14%
23. Body Composition 12%
24. Incidence 12%
25. Quality of Life 11%
26. Anemia 10%
27. Registries 10%
28. Fats 9%
29. Forced Expiratory Volume 9%
30. Cardiac Catheterization 9%
31. Lung Volume Measurements 8%
32. Spirometry 8%
33. Therapeutics 7%
34. Exercise 7%
35. Brain Natriuretic Peptide 7%
36. Gases 7%
37. Exercise Tolerance 6%
38. Analysis of Variance 6%
39. Equipment and Supplies 6%
40. Logistic Models 6%
41. Markov Chains 6%
42. Dyspnea 6%
43. Body Weights and Measures 6%
44. Vascular Resistance 5%
45. Transplants 5%
46. Physical Functional Performance 5%
47. Lung 5%